ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

Sebastiano Buti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.